[1] MOKDAD AA,LOPEZ AD,SHAHRAZ S,et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010:A systematic analysis[J]. BMC Med,2014,12:145.
|
[2] TAPPER EB,PARIKH ND. Mortality due to cirrhosis and liver cancer in the United States,1999-2016:Observational study[J]. BMJ,2018,362:k2817.
|
[3] WANGJIA ML,LI SB. Hepatology[M]. Beijing:People's Medical Publishing House,2013:630-631.(in Chinese)王家马龙,李绍白.肝脏病学[M].北京:人民卫生出版社,2013:630-631.
|
[4] BAKI JA,TAPPER EB. Contemporary epidemiology of cirrhosis[J]. Curr Treat Options Gastroenterol,2019,17(2):244-253.
|
[5] PALARETI G COSMI B,LEGNANI C,et al. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism:A management study[J]. Blood,2014,124(2):196-203.
|
[6] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
[7] LYU J,DONG SS,GU HT,et al. TCM syndrome characteristics of portal vein thrombosis in patients with liver cirrhosis and related risk factors[J]. J Clin Hepatol,2019,35(10):2210-2213.(in Chinese)吕靖,董思思,顾宏图,等.肝硬化并发门静脉血栓的危险因素及中医证候特点[J].临床肝胆病杂志,2019,35(10):2210-2213.'
|
[8] QIAN HC,LU ZQ,ZHANG TP. Clinical significance of procalcitonin combined with D-dimer in assessment of the severity of acute cholangitis[J]. J Clin Exp Med,2019,18(18):1949-1952.(in Chinese)钱海超,芦照青,张天鹏.血浆降钙素原与D-二聚体水平在判断急性胆管炎病情严重程度中的临床价值[J].临床和实验医学杂志,2019,18(18):1949-1952.
|
[9] SUN HS,ZHU H,GAO HY,et al. Value of combined detection of tumor markers SCC-Ag,CEA,CYFRA21-1 and Ddimer in early diagnosis of non-small cell lung cancer[J]. J Jilin Univ(Med Edit),2018,44(5):1020-1024.(in Chinese)孙洪帅,朱华,高海燕,等.肿瘤标志物SCC-Ag、CEA、CYFRA21-1和D-二聚体联合检测对非小细胞肺癌的早期诊断价值[J].吉林大学学报(医学版),2018,44(5):1020-1024.
|
[10] LE GAL G,RIGHINI M,WELLS PS. D-dimer for pulmonary embolism[J]. JAMA,2015,313(16):1668-1669.
|
[11] DROLZ A,HORVATITS T,ROEDL K,et al. Coagulation parameters and major bleeding in critically ill patients with cirrhosis[J]. Hepatology,2016,64(2):556-568.
|
[12] RAUTOU PE,VION AC,LUYENDYK JP,et al. Circulating microparticle tissue factor activity is increased in patients with cirrhosis[J]. Hepatology,2014,60(5):1793-1795.
|
[13] LI Y,QI X,LI H,et al. D-dimer level for predicting the inhospital mortality in liver cirrhosis:A retrospective study[J].Exp Ther Med,2017,13(1):285-289.
|
[14] PUGH RN,MURRAY-LYON IM,DAWSON JL,et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg,1973,60(8):646-649.
|
[15] KAMATH PS,WIESNER RH,MALINCHOC M,et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology,2001,33(2):464-470.
|
[16] QI T,ZHU C,LU G,et al. Elevated D-dimer is associated with increased 28-day mortality in acute-on-chronic liver failure in China:A retrospective study[J]. BMC Gastroenterol,2019,19(1):20.
|
[17] WANNHOFF A,MLLER OJ,FRIEDRICH K,et al. Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis[J]. PLo S One,2014,9(11):e112583.
|
[18] SMALBERG JH,KOEHLER E,DARWISH MURAD S,et al. Fibrinogenγ'and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis[J]. Thromb Haemost,2013,109(3):558-560.
|
[19] SENZOLO M,SIMIONI P,ANDRIULLI A. Screening and treatment of portal vein thrombosis in cirrhosis[J]. Dig Liver Dis,2017,49(2):228-229.
|
[20] XIONG JP,PENG YY,ZHANG YX. Screening for differentially expressed proteins in patients with liver cirrhosis complicated by portal vein thrombosis[J]. J Clin Hepatol,2018,34(1):112-117.(in Chinese)熊静平,彭媛媛,张跃新.肝硬化合并门静脉血栓患者的差异蛋白筛选[J].临床肝胆病杂志,2018,34(1):112-117.
|
[21] CUI S,FU Z,FENG Y,et al. The disseminated intravascular coagulation score is a novel predictor for portal vein thrombosis in cirrhotic patients with hepatitis B[J]. Thromb Res,2018,161:7-11.
|
[22] WEI Y,CHEN X,SHEN H,et al. P-selectin level at first and third day after portal hypertensive splenectomy for early prediction of portal vein thrombosis in patients with cirrhosis[J].Clin Appl Thromb Hemost,2018,24(9 Suppl):76s-83s.
|
[23] MALAGUARNERA M,LATTERI S,BERTINO G,et al. D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis[J]. Clin Exp Gastroenterol,2018,11:373-380.
|
[24] DAI J,QI X,LI H,et al. Role of D-dimer in the development of portal vein thrombosis in liver cirrhosis:A Meta-analysis[J]. Saudi J Gastroenterol,2015,21(3):165-174.
|
[25] MALAGUARNERA G,VACANTE M,DRAGO F,et al. Endozepine-4 levels are increased in hepatic coma[J]. World J Gastroenterol,2015,21(30):9103-9110.
|